Drugs / GSK4528287
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06681181 | Nov 2024 → Apr 2026 overdue | ulcerative colitis | GlaxoSmithKline | Active not recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSK4528287 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06681181 ↗ |